These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25691218)

  • 1. Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease.
    Avin KG; Moorthi RN
    Curr Osteoporos Rep; 2015 Jun; 13(3):173-9. PubMed ID: 25691218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of sarcopenia in chronic kidney disease.
    Moorthi RN; Avin KG
    Curr Opin Nephrol Hypertens; 2017 May; 26(3):219-228. PubMed ID: 28198733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Sarcopenia and risk of osteoporosis, falls and bone fractures in patients with chronic kidney disease: A systematic review".
    Rashid A; Chaudhary Hauge S; Suetta C; Hansen D
    PLoS One; 2022; 17(1):e0262572. PubMed ID: 35061818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragility fracture risk and skeletal muscle function.
    Pérez-López FR; Ara I
    Climacteric; 2016; 19(1):37-41. PubMed ID: 26588486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise and CKD: Skeletal Muscle Dysfunction and Practical Application of Exercise to Prevent and Treat Physical Impairments in CKD.
    Roshanravan B; Gamboa J; Wilund K
    Am J Kidney Dis; 2017 Jun; 69(6):837-852. PubMed ID: 28427790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.
    Enoki Y; Watanabe H; Arake R; Fujimura R; Ishiodori K; Imafuku T; Nishida K; Sugimoto R; Nagao S; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
    J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):735-747. PubMed ID: 28608457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of Skeletal Muscle to Counteract Sarcopenia in Patients with Advanced Chronic Kidney Disease and Especially Those Undergoing Hemodialysis.
    Mori K
    Nutrients; 2021 May; 13(5):. PubMed ID: 34063269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle mass and plasma myostatin after exercise training: a substudy of Renal Exercise (RENEXC)-a randomized controlled trial.
    Zhou Y; Hellberg M; Hellmark T; Höglund P; Clyne N
    Nephrol Dial Transplant; 2021 Jan; 36(1):95-103. PubMed ID: 31848626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal Muscle Complications in Chronic Kidney Disease.
    Troutman AD; Arroyo E; Lim K; Moorthi RN; Avin KG
    Curr Osteoporos Rep; 2022 Dec; 20(6):410-421. PubMed ID: 36149594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies.
    Heitman K; Alexander MS; Faul C
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.
    Sato E; Mori T; Mishima E; Suzuki A; Sugawara S; Kurasawa N; Saigusa D; Miura D; Morikawa-Ichinose T; Saito R; Oba-Yabana I; Oe Y; Kisu K; Naganuma E; Koizumi K; Mokudai T; Niwano Y; Kudo T; Suzuki C; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Sci Rep; 2016 Nov; 6():36618. PubMed ID: 27830716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions.
    Watanabe H; Enoki Y; Maruyama T
    Biol Pharm Bull; 2019; 42(9):1437-1445. PubMed ID: 31474705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia in chronic kidney disease.
    Souza VA; Oliveira Dd; Mansur HN; Fernandes NM; Bastos MG
    J Bras Nefrol; 2015; 37(1):98-105. PubMed ID: 25923756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated concept of sarcopenia based on muscle-bone relationship.
    Yakabe M; Hosoi T; Akishita M; Ogawa S
    J Bone Miner Metab; 2020 Jan; 38(1):7-13. PubMed ID: 31583540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interaction.
    Tarantino U; Piccirilli E; Fantini M; Baldi J; Gasbarra E; Bei R
    J Bone Joint Surg Am; 2015 Mar; 97(5):429-37. PubMed ID: 25740034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study.
    Lee SM; Han MY; Kim SH; Cha RH; Kang SH; Kim JC; An WS
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone and skeletal muscle: neighbors with close ties.
    DiGirolamo DJ; Kiel DP; Esser KA
    J Bone Miner Res; 2013 Jul; 28(7):1509-18. PubMed ID: 23630111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia in chronic kidney disease: from bench to bedside.
    Kim DW; Song SH
    Korean J Intern Med; 2023 May; 38(3):303-321. PubMed ID: 37077132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical manifestation and pathophyisological bases of sarcopenia.].
    Ogawa S
    Clin Calcium; 2016; 26(12):1703-1708. PubMed ID: 27885181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Musculoskeletal Health in the Context of Spinal Cord Injury.
    Clark JM; Findlay DM
    Curr Osteoporos Rep; 2017 Oct; 15(5):433-442. PubMed ID: 28842819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.